2024: 14th Northern Ireland Conference of the Primary Care Diabetes Society
This site is intended for healthcare professionals only
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
We would like to invite you to the 14th Northern Ireland Conference of the Primary Care Diabetes Society (PCDS), taking place on 19 September 2024 in Belfast.
Organised by the PCDS, the only association solely committed to the needs of primary care diabetes, this conference will examine diabetes care from a Northern Irish perspective. Through a mixture of lectures and masterclasses, this event will provide practical guidance to healthcare professionals, focusing on those issues that have the most impact on everyday diabetes practice in Northern Ireland.
As the Northern Irish representatives of the PCDS Committee, we are delighted to be delivering an event that provides an invaluable opportunity for us to come together and discuss the real core issues in day-to-day diabetes care delivery in Northern Ireland.
We look forward to welcoming you to this event.
Masterclasses offering hands-on tips that will influence your everyday clinical practice
Inspiration and new contacts with various opportunities to network alongside your peers
Claim 5 CPD points for the one-day conference
19 September 2024 - 09:00am
Registration, refreshments and exhibition viewing
Chair’s Introduction
Heather Bell & Lesley HamiltonUnderstanding obesity using the 5 A’s management framework
This symposium is funded by Lilly. Lilly has provided a sponsorship towards this conference, however have had no input, control, or influence over the agenda, speaker selections, presentations, or collateral content, except for this symposium session.
PP-LD-GB-2592 August 2024
Chair Dr Heather Bell, Speaker Dr Eimear DarcyOncology and palliative care
Su DownRefreshments & exhibitions viewing
Masterclass rotation 1:
Networking – Elaine King
Masterclass 2: Diet – Alison Birch
Masterclass 3: Continuous glucose monitoring – Heather Bell
Masterclass 4: Podiatory – Jennifer Madden
VariousMasterclass change around
Masterclass rotation 2:
Masterclass 1: Networking – Elaine King
Masterclass 2: Diet – Alison Birch
Masterclass 3: Continuous glucose monitoring – Heather Bell
Masterclass 4: Podiatory – Jennifer Madden
VariousLunch and exhibition viewing
Managing kidney risk in T2DM and the role of the General Practice Pharmacist
This is a promotional symposium sponsored and organised by AstraZeneca, intended for NI HCPs only.
Dr Richard McCrory, Glynis McMurtry & Maura CorryInsulin dilemmas
Dr Neil BlackRefreshments and exhibition viewing
Psychological Care in Diabetes
Dr Becky HoughtonBreaking news, brought to you by Diabetes Distilled
Pam BrownChairs’ concluding remarks
Heather Bell & Lesley Hamilton 
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.
With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 35 different medicines to the NHS.
For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK.
Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.
Directions: Paradise Walk, Castle Upton Estate, Templepatrick, BT39 0DD, N. Ireland
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
